Cycle Pharmaceuticals

Rare disease medicines and patient support programmes for oncology, neurology, metabolic and immunology conditions

Cambridge, United KingdomFounded 2012cyclepharma.comWebsite technologies

+ Add to sales board

Highlights

  • Hiring14 open roles
  • New on EvolcAdded 2026-10-23
  • Remote-friendly14 of 14 open roles remote or hybrid

About Cycle Pharmaceuticals

Cycle Pharmaceuticals develops and markets treatments for rare diseases across oncology, neurology, metabolic and immunological conditions. Its US-approved products include CAVHANZA (nilotinib), PHYRAGO (dasatinib), HARLIKU and NITYR (nitisinone), BAFIERTAM and ORMALVI, and it offers the Cycle Vita patient support programme in the US alongside a Free Goods Programme for patients in countries where they are unlikely to afford rare disease medication.

The customers are patients with rare conditions and their caregivers, served through prescribers and hospitals. The company describes its offering as treatments plus support services, including continuous patient support and nutrition support through Registered Dietitians.

Cycle Pharma was founded in 2012 and lists offices in Cambridge (UK) and Detroit, Michigan (US), with more than 100 employees. Its open roles are mainly in clinical development, US oncology sales, marketing, quality and supply chain, with most based in Cambridge.

Product: Prescription medicines for rare diseases (oncology, neurology, metabolic, immunology) and the Cycle Vita patient support programme.

Jobs at Cycle Pharmaceuticals (14)

Cycle Pharmaceuticals is hiring for 14 roles, mostly in sales, based in Cambridge. 5 are remote.

See all 14 jobs at Cycle Pharmaceuticals →

Companies hiring like Cycle Pharmaceuticals

Leadership

More biotech & pharma companies

  • Cyden

    Manufacturer of energy-based at-home skin and hair devices for consumer and professional beauty markets
    Swansea, United KingdomBiotech & pharmaFounded 2002
    New on Evolc
  • Dna Worldwide Group Holdings

    DNA testing and related forensic services for individuals, families, immigration applicants and legal cases
    Frome, United KingdomBiotech & pharmaFounded 2023
    Young companyNew on Evolc
  • Dnae Group Holdings

    Point-of-need semiconductor DNA sequencing diagnostics for infection testing in hospital settings, developed in London
    London, United KingdomBiotech & pharmaFounded 2003
    New on Evolc
  • Draig Therapeutics

    Develops neuropsychiatric drug therapies for patients with depression and other brain disorders
    Cardiff, United KingdomBiotech & pharmaFounded 2021
    New on Evolc
  • Duke Street Bio

    Develops cancer therapies targeting DNA damage repair deficiencies for patients with cancer
    London, United KingdomBiotech & pharmaFounded 2020
    New on Evolc
  • Elasmogen

    Biopharma developing ELN28, a dual-acting TNFα and JAK inhibitor conjugate for hidradenitis suppurativa patients
    Foresterhill, United KingdomBiotech & pharmaFounded 2014
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Google Tag Manager
  • Greenhouse
  • WordPress
  • jQuery
  • nginx